Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Appian
APPN
$2.68B
| $4.7M | ﹤0.01% |
132,640
+4,854
| +4% | +$173K |
2019 Q1
27 quarters
|
|
2252
ESAB
ESAB
$4.51B
| $4.69M | ﹤0.01% |
42,023
-22,176
| -35% | -$2.54M |
2022 Q2
14 quarters
|
|
|
LX
2253
LexinFintech Holdings
LX
$112M
| $4.69M | ﹤0.01% |
1,435,075
+1,208,321
| +533% | +$4.96M |
2024 Q4
4 quarters
|
|
|
JOYY
2254
JOYY Inc
JOYY
$3.94B
| $4.69M | ﹤0.01% |
72,415
+45,864
| +173% | +$2.8M |
2022 Q1
15 quarters
|
|
|
CURB
2255
Curbline Properties
CURB
$3.25B
| $4.68M | ﹤0.01% |
201,431
+32,634
| +19% | +$761K |
2024 Q4
4 quarters
|
|
2256
Customers Bancorp
CUBI
$2.55B
| $4.67M | ﹤0.01% |
63,824
+18,959
| +42% | +$1.3M |
2016 Q1
39 quarters
|
|
2257
Steven Madden
SHOO
$3.36B
| $4.66M | ﹤0.01% |
111,993
+8,073
| +8% | +$311K |
2013 Q2
50 quarters
|
|
|
JKS
2258
PUT
JinkoSolar
JKS
$469M
| $4.65M | ﹤0.01% |
+180,000
| New | +$4.59M |
2025 Q4
0 quarters
|
|
2259
PUT
Merck
MRK
$345B
| $4.64M | ﹤0.01% |
44,100
+9,700
| +28% | +$911K |
2024 Q3
5 quarters
|
|
2260
Brunswick
BC
$4.22B
| $4.62M | ﹤0.01% |
62,254
-18,352
| -23% | -$1.24M |
2013 Q2
50 quarters
|
|
|
SFD
2261
Smithfield Foods
SFD
$7.43B
| $4.61M | ﹤0.01% |
206,484
+1,433
| +0.7% | +$31.5K |
2025 Q1
3 quarters
|
|
2262
Freshworks
FRSH
$3.38B
| $4.6M | ﹤0.01% |
375,577
+32,085
| +9% | +$379K |
2022 Q1
15 quarters
|
|
2263
CALL
Ultragenyx Pharmaceutical
RARE
$1.44B
| $4.6M | ﹤0.01% |
200,000
| – | – |
2025 Q1
3 quarters
|
|
2264
Intellia Therapeutics
NTLA
$1.72B
| $4.6M | ﹤0.01% |
511,240
+23,014
| +5% | +$317K |
2016 Q2
38 quarters
|
|
2265
Chesapeake Utilities
CPK
$3.2B
| $4.6M | ﹤0.01% |
36,831
+4,354
| +13% | +$574K |
2013 Q2
50 quarters
|
|
2266
CALL
eBay
EBAY
$47.6B
| $4.58M | ﹤0.01% |
52,600
| – | – |
2025 Q2
2 quarters
|
|
2267
Sonoco
SON
$4.78B
| $4.57M | ﹤0.01% |
104,696
-92,032
| -47% | -$3.81M |
2013 Q2
50 quarters
|
|
2268
MGE Energy Inc
MGEE
$2.69B
| $4.57M | ﹤0.01% |
58,221
-49,603
| -46% | -$4.08M |
2016 Q3
37 quarters
|
|
2269
Grocery Outlet
GO
$1.14B
| $4.56M | ﹤0.01% |
451,056
+44,888
| +11% | +$565K |
2019 Q3
25 quarters
|
|
2270
Amneal Pharmaceuticals
AMRX
$7.12B
| $4.55M | ﹤0.01% |
361,238
+16,639
| +5% | +$190K |
2018 Q2
30 quarters
|
|
2271
Alliance Resource Partners
ARLP
$3.19B
| $4.55M | ﹤0.01% |
195,879
-461,312
| -70% | -$11.2M |
2025 Q2
2 quarters
|
|
2272
Comstock Resources
CRK
$3.85B
| $4.55M | ﹤0.01% |
196,286
+8,155
| +4% | +$180K |
2013 Q2
50 quarters
|
|
2273
Sonos
SONO
$2.06B
| $4.55M | ﹤0.01% |
258,991
+91,469
| +55% | +$1.59M |
2018 Q3
29 quarters
|
|
2274
Liquidia Corp
LQDA
$2.53B
| $4.55M | ﹤0.01% |
131,814
+23,948
| +22% | +$682K |
2022 Q2
14 quarters
|
|
2275
CALL
Kimberly-Clark
KMB
$31.5B
| $4.54M | ﹤0.01% |
+45,000
| New | +$4.92M |
2025 Q4
0 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.